Article Text

Download PDFPDF
35 Carer-administration of as-needed sub-cutaneous medication for breakthrough symptoms in homebased dying patients: a uk study (CARIAD)
  1. Clare Wilkinson1,
  2. Marlise Poolman1,
  3. Jessica Roberts1,
  4. Bee Wee2,
  5. Julia Hiscock1,
  6. Dyfrig Hughes1,
  7. Annmarie Nelson3,
  8. Paul Perkins4,
  9. Rosalynde Johnstone5,
  10. Liz Reymond6,
  11. Betty Foster7,
  12. Julie O’Connor8,
  13. Sian Jones5,
  14. Zoe Hoare1,
  15. Rossela Roberts5,
  16. Anthony Byrne9,
  17. Sue Healy6 and
  18. Penney Lewis10
  1. 1Bangor University, UK
  2. 2University of Oxford, UK
  3. 3Cardiff University, UK
  4. 4Gloucestershire Hospitals NHS Foundation Trust, UK
  5. 5Betsi Cadwaladr University Health Board, UK
  6. 6Queensland Health Metro South Hospital Health Service, Australia
  7. 7North Wales Cancer Network Patient Forum, UK
  8. 8Leckhampton Court Hospice, UK
  9. 9Cardiff and Vale University Local Health Board, UK
  10. 10The Dickson Poon School of Law, UK


Introduction Whilst the majority of seriously ill people express a wish to die at home (79%), only half of those achieve this. The likelihood of patients remaining at home often depends on availability of able and willing informal carers who take on numerous care tasks, often including the responsibility of assisting patients with oral medications. The role of carers administering subcutaneous injections is not widespread practice in the UK, but has proven to be key in achieving home death in other countries.

Aim To determine if carer-administration of as-needed subcutaneous medication for four breakthrough symptoms (pain, nausea, restlessness and noisy breathing) in homebased dying patients is feasible and acceptable in the UK.

Methods One hundred adult patients in the last weeks of life who are likely to lose the oral route and have expressed a preference to die at home will be recruited with their carers to an external randomised pilot trial across three UK sites (North Wales, South Wales and Gloucestershire). Carers randomised to the intervention arm will receive a manualised training package adapted from an existing Australian model and delivered by local district nursing teams. Dyads in the control arm will receive usual care.

Results The main outcomes of interest will be feasibility, acceptability, recruitment rates, attrition and selection of the most appropriate outcomes measures.

Conclusion Findings will inform a definitive Phase III randomised controlled trial.

The study is funded by the National Institute for Health Research (HTA project 15/10/37). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.